Loading company
Latest annual · FY2025
Millions- Operating income
- (12)
- Net income
- (12)
Latest quarter · Q2 FY2026
Millions- Operating income
- (4)
- Net income
- (3)
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$11.9 million | -$7.7 million | 10-K 2026-03-31 · proof | |
| Net income | -$11.7 million | -$9.1 million | 10-K 2026-03-31 · proof | |
| Cash from operating activities | -$9.5 million | -$7.3 million | 10-K 2026-03-31 · proof | |
| Total assets | $10.5 million | $2.5 million | +318% | 10-K 2026-03-31 · proof |
| Total liabilities | $8.2 million | $1.8 million | +357.5% | 10-K 2026-03-31 · proof |
| Cash and cash equivalents | $334,005 | $1.9 million | -82.6% | 10-K 2026-03-31 · proof |
- What was Shuttle Pharmaceuticals Holdings, Inc. (SHPH)'s operating income in fiscal 2025?
- Shuttle Pharmaceuticals Holdings, Inc. (SHPH) reported operating income of -$11.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$7.7 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was Shuttle Pharmaceuticals Holdings, Inc. (SHPH)'s net income in fiscal 2025?
- Shuttle Pharmaceuticals Holdings, Inc. (SHPH) reported net income of -$11.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -$9.1 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was Shuttle Pharmaceuticals Holdings, Inc. (SHPH)'s cash from operating activities in fiscal 2025?
- Shuttle Pharmaceuticals Holdings, Inc. (SHPH) reported cash from operating activities of -$9.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$7.3 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Shuttle Pharmaceuticals Holdings, Inc. (SHPH)'s total assets?
- As of Dec 31, 2025, Shuttle Pharmaceuticals Holdings, Inc. (SHPH) reported total assets of $10.5 million, against $2.5 million a year earlier (+318%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Shuttle Pharmaceuticals Holdings, Inc. (SHPH)'s total liabilities?
- As of Dec 31, 2025, Shuttle Pharmaceuticals Holdings, Inc. (SHPH) reported total liabilities of $8.2 million, against $1.8 million a year earlier (+357.5%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Shuttle Pharmaceuticals Holdings, Inc. (SHPH)'s cash and cash equivalents?
- As of Dec 31, 2025, Shuttle Pharmaceuticals Holdings, Inc. (SHPH) reported cash and cash equivalents of $334,005, against $1.9 million a year earlier (-82.6%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:SHPH&period_type=annual&limit=5"Information only, not investment advice.